| 1 |
Marti-aguado D, Clemente-sanchez A, Bataller R. Cigarette Smoking and Liver Diseases. Journal of Hepatology 2022. [DOI: 10.1016/j.jhep.2022.01.016] [Reference Citation Analysis]
|
| 2 |
Lu ZN, Shan Q, Hu SJ, Zhao Y, Zhang GN, Zhu M, Yu DK, Wang JX, He HW. Discovery of 1,8-naphthalidine derivatives as potent anti-hepatic fibrosis agents via repressing PI3K/AKT/Smad and JAK2/STAT3 pathways. Bioorg Med Chem 2021;49:116438. [PMID: 34610571 DOI: 10.1016/j.bmc.2021.116438] [Reference Citation Analysis]
|
| 3 |
Rupcic Rubin V, Bojanic K, Smolic M, Rubin J, Tabll A, Smolic R. An Update on Efficacy and Safety of Emerging Hepatic Antifibrotic Agents. J Clin Transl Hepatol 2021;9:60-70. [PMID: 33604256 DOI: 10.14218/JCTH.2020.00040] [Reference Citation Analysis]
|
| 4 |
Hara T, Ohara T, Taniguchi M, Sakai T, Oka K, Iwai N, Tsuji T, Okuda T, Komaki T, Sakagami J, Kagawa K. Development of Hepatocellular Carcinoma in a Patient with Chronic Hepatitis C 21 Years after Achieving a Sustained Virological Response to Interferon Therapy. Case Reports Hepatol 2020;2020:8824974. [PMID: 33123390 DOI: 10.1155/2020/8824974] [Reference Citation Analysis]
|
| 5 |
Zhou HJ, Cao J, Shi H, Naidoo N, Semba S, Wang P, Fan YF, Zhu SC. Cost-Effectiveness Analysis of Pan-Genotypic Sofosbuvir-Based Regimens for Treatment of Chronic Hepatitis C Genotype 1 Infection in China. Front Public Health 2021;9:779215. [DOI: 10.3389/fpubh.2021.779215] [Reference Citation Analysis]
|
| 6 |
Guaraldi G, Milic J. Vitamin E as a 'bridge' therapy for nonalcoholic steatohepatits in HIV: what is waiting on the other side of the bridge? AIDS 2020;34:317-9. [PMID: 31876593 DOI: 10.1097/QAD.0000000000002413] [Reference Citation Analysis]
|
| 7 |
Schlevogt B, Boeker KHW, Mauss S, Klinker H, Heyne R, Link R, Simon KG, Sarrazin C, Serfert Y, Manns MP, Wedemeyer H. Weight Gain after Interferon-Free Treatment of Chronic Hepatitis C-Results from the German Hepatitis C-Registry (DHC-R). Biomedicines 2021;9:1495. [PMID: 34680612 DOI: 10.3390/biomedicines9101495] [Reference Citation Analysis]
|
| 8 |
Rupcic Rubin V, Bojanic K, Smolic M, Rubin J, Tabll A, Smolic R. An Update on Efficacy and Safety of Emerging Hepatic Antifibrotic Agents. J Clin Transl Hepatol 2021;9:60-70. [PMID: 33604256 DOI: 10.14218/JCTH.2020.00040] [Reference Citation Analysis]
|
